Slide background
TIME magazine has named PAVIR PI

Tony Wyss-Coray

one of the 50 most influential people
in health care.

Read the article
Learn more about Dr. Wyss-Coray’s work

Slide background
We are pleased to announce PAVIR’s new mission statement reflecting a more purpose-driven direction.

Advancing Veteran and public health
through innovative research

Slide background

Dr. Nicolls’ work on leukotriene B4 (LTB4) and its role in acquired Lymphedema published in the 5/10/17 edition of the Science Translational Medicine journal. Clinical Trial to test potential drug compound integrating Dr. Nicolls’ basic science laboratory findings.
Read more

High Impact Publication:

Slide background
is a major overarching interest in our pursuit of health improvements for Veterans. We believe that advances in genomics will make personalized medicine a reality.

Genomic medicine

Get Involved

PAVIR thanks all of our study participants for volunteering. Your involvement is fundamental to our cause.

For More information and to get involved,
Click Here >  

Board of Directors

PAVIR has a tradition of focusing on researchers’ needs.  It is a privilege to be involved in leading PAVIR, and I am committed to PAVIR’s action-oriented and process improvement culture. My efforts as Board Chair focus on PAVIR’s role in promoting the best possible clinical and bench research at the VAPAHCS. — Mark Nicolls, M.D., Board Chair

Meet the Board >

Window Into Our Research

Phil Tsao, PhD receives initial VA funding to study VA’s own Million Veteran Program Data

Phil Tsao, PhD, VA Associate Chief of Staff, Research, VA Palo Alto Health Care System (VAPAHCS) and PAVIR Board member, receives initial VA funding to study VA’s own Million Veteran Program Data. PAVIR collaborates with VAPAHCS in advancing genomic medicine, which is a major overarching interest in our pursuit of health improvements for Veterans. We believe that advances in genomics will make personalized medicine a reality.
LEARN MORE >